DB CALNE, J KEBABIAN, E SILBERGELD, … - Annals of Internal …, 1979 - Am Coll Physicians Advances through basic research have elucidated the disturbances of neurotransmitter function
in Parkinson's disease, with findings directly applicable to drug therapy. Dopamine has replaced
acetylcholine and norepinephrine as the most studied neurotransmitter, with both ... Cited by 16 - Related articles - All 2 versions
[CITATION] The absence of dying-back in the phrenic nerve in amyotrophic lateral sclerosis ( …
JA Brockman - US Patent 3,989,819, 1976 - Google Patents US Patent NOV. 2,1976 sheet 3 of 4 3,989,819 2.0 IO _L _L j_ I 20 4O 60 TUBE NO. (Co. 5
ML/TUBE) 0.4 0.2 10 30 5O TUBE NO. (Co. 15ML/TUBE) ... US Patent NOV. 2,1976 sheet 4
of 4 3,989,819 JI I S i fi s a Ci ... 3,989,819 1 2 s such as to Cause any significant degree ... Cited by 2 - Related articles - All 2 versions
[CITATION] Phar macological protection against the cytotoxicity induced by 6- …
HL Klawans, C Goetz, PA Nausieda, WJ … - … in experimental medicine …, 1977 - ncbi.nlm.nih.gov 1: Adv Exp Med Biol. 1977;90:21-47. Recent advances in the biochemical pharmacology
of extrapyramidal movement disorders. Klawans HL, Goetz C, Nausieda PA, Weiner
WJ. Mesh Terms: Animals; Corpus Striatum/physiopathology; ... Cited by 3 - Related articles
